Cargando…
Safety and efficacy of lecanemab for Alzheimer's disease: a systematic review and meta-analysis of randomized clinical trials
OBJECTIVE: We performed a systematic review and meta-analysis of the cognitive effectiveness and safety of lecanemab on subjects with Alzheimer's disease (AD). METHODS: We screened the literature published before February 2023 in PubMed, Embase, Web of Science, and Cochrane that were searched f...
Autores principales: | Qiao, Yue, Chi, Yuewei, Zhang, Qingyuan, Ma, Ying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10196238/ https://www.ncbi.nlm.nih.gov/pubmed/37213538 http://dx.doi.org/10.3389/fnagi.2023.1169499 |
Ejemplares similares
-
Efficacy and Safety of Probiotics for the Treatment of Alzheimer's Disease, Mild Cognitive Impairment, and Parkinson's Disease: A Systematic Review and Meta-Analysis
por: Xiang, Shuai, et al.
Publicado: (2022) -
Reply: Unblinding in the lecanemab trial in Alzheimer’s disease
por: Hardy, John, et al.
Publicado: (2023) -
Effectiveness and safety of ginkgo biloba preparations in the treatment of Alzheimer's disease: A systematic review and meta-analysis
por: Li, Dawei, et al.
Publicado: (2023) -
Safety and Efficacy of Nusinersen and Risdiplam for Spinal Muscular Atrophy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Qiao, Yue, et al.
Publicado: (2023) -
The efficacy and safety of anti-Aβ agents for delaying cognitive decline in Alzheimer’s disease: a meta-analysis
por: Li, Jiaxuan, et al.
Publicado: (2023)